Examining how inhaler use affects asthma treatment outcomes
Influence of Inhaler Compliance on the Treatment of Asthma Patients
This study tests if sending reminders to adults with mild to moderate asthma about using their inhalers helps them manage their symptoms better than those who don’t get reminders.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 150 (estimated) |
| Ages | 20 Years to 80 Years |
| Sex | All |
| Sponsor | Taipei Medical University Hospital Academic / other |
| Locations | 1 site (Taipei) |
| Trial ID | NCT06108908 on ClinicalTrials.gov |
What this trial studies
This study investigates the impact of inhaler compliance on treatment outcomes in adult patients with mild to moderate persistent asthma. Participants will use Asthma Supportive Kits for 24 weeks, which monitor their inhaler usage. They will be randomly assigned to either an intervention group, receiving reminders for medication adherence, or a control group, which will not receive reminders. The study aims to compare compliance rates and asthma control status between the two groups over the study period.
Who should consider this trial
Good fit: Ideal candidates are adults aged 20-80 with mild to moderate persistent asthma who are willing to use Budesonide+Formoterol and comply with study protocols.
Not a fit: Patients with uncontrolled systemic diseases or those who inadequately use inhalers may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve asthma management and reduce exacerbation events through enhanced medication adherence.
How similar studies have performed: Previous studies have shown that interventions aimed at improving medication adherence can lead to better asthma control, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Adult asthmatic patients (20-80 years old) 2. With mild to moderate persistent asthma according to ATS definition and diagnosis 3. Willing to use Budesonide+Formoterol. 4. Adequately use inhaler 5. Without evident intentional non-adherence 6. Agree asthma is a common and potentially serious chronic disease 7. Willing to sign Informed Consent Form Exclusion Criteria: 1. Inadequately use inhaler 2. Disagree asthma is a common and potentially serious chronic disease 3. With uncontrolled systemic diseases, such as hypertension, heart failure, renal failure, de-compensated liver cirrhosis, etc.;
Where this trial is running
Taipei
- Taipei Medical University, Taiwan, R.O.C. — Taipei, Taiwan (Recruiting)
Study contacts
- Principal investigator: Han-Pin KUO — Taipei Medical University, Taiwan, R.O.C.
- Study coordinator: Han-Pin KUO
- Email: hpk8828@gmail.com
- Phone: +886975368066
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.